Foundery Immune Studio, LLC Acquires Rights to a Suite of Next-Generation Clinical Stage Immunotherapies
January 8, 2025
Foundery Immune Studio, LLC, a biotechnology venture studio focused on translating immunology discoveries into medicines, announced its acquisition of worldwide rights for three clinical-stage immune